Forbes

AI‑designed intracellular antibody fragments can stay stable inside cells and bind misfolded proteins, opening new treatment routes for diseases.

Membership medicine is booming. Medicare’s new APCM codes, combined with technology-enabled care delivery partners, offer a path to scale concierge-style care beyond those who can afford it.

Peptides are everywhere—from longevity clinics to social media. But not everyone is qualified to give advice. Here’s what to know before you trust the trend.

The 49ers investigated a conspiracy theory—not to validate it, but to remove doubt. A lesson for leaders navigating uncertainty, risk and decisionmaking.

New JAMA studies examine whether routine colonoscopies and low‑dose thyroid drugs benefit older adults, raising questions about risks, costs and continued use.

Nearly 200 blood proteins rise and fall across the menstrual cycle, enabling a test that pinpoints cycle day and links it to risks like fibroids and heavy bleeding.

Eliminating flu and COVID-19 vaccine requirements threatens our military preparedness and goes against data. Will Hegseth go after other vaccine-preventable infections next?

With conflicts escalating in many parts of the world, we're seeing an upsurge in malaria cases and deaths. In some cases, the disease kills more people than the fighting.

In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.

An overactive immune switch in the placenta may drive preeclampsia; blocking it in models reverses key disease pathways, pointing toward targeted therapies.

Hegseth's decision to allow military servicemembers to refuse flu vaccination contradicts U.S. military doctrine and the lesson of WWI, when flu killed 45,000 U.S. troops

The people who research, make and invest in vaccines are nervous. Some companies have started pulling back on their vaccine work.

A shrimp virus called CMNV has jumped into humans, causing a new eye disease linked to handling and eating raw seafood. The virus is already global.

Elevance Health reported $1.7 billion in first quarter net income as cost issues continued to drag on earnings of the nation’s second-largest health insurer.